Assurance Infusion recalls BUP 675MCG/MORP 20MG/ML in 20mL syringes due to lack of sterility assurance. Affected lots: 12122019@12 expiring 12/21/2019.
Lack of sterility assurance.
Assurance Infusion is recalling a specific medication syringe because it may not be sterile. This could lead to infections if used improperly. Patients should check their lot numbers and contact the manufacturer for details.
The syringe lacks sterility assurance, meaning it may not be clean enough to prevent infections. This could cause serious infections if the medication is injected into the body.
Patients using this medication syringe are affected. Those with the lot number 12122019@12 (expiring 12/21/2019) are most at risk.
Check for the lot number 12122019@12 on the syringe packaging. The syringe is labeled as BUP 675MCG/MORP 20MG/ML in 20 mL.
Look for the lot number 12122019@12 on the syringe packaging.
BUP 675MCG/MORP 20MG/ML in 20 mL syringe from Assurance Infusion.
Lack of sterility assurance, which could lead to infections if used.
Check for the lot number 12122019@12 on the syringe packaging.
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0716-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0716-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
